Holistic lifestyle interventions outshine drugs in preventing cardiometabolic diseases

Comprehensive lifestyle interventions prevent cardiometabolic diseases effectively but face challenges in routine care and require supportive policies for lasting impact.

AstraZeneca hopes to make clinical trial operations carbon-negative by 2030

AstraZeneca has spoken about how they are delivering ambitious plans to help other pharma companies follow suit. Image credit: AstraZeneca. AstraZeneca has big plans to

September 6, 2023

Arf1 inhibition induces tumor regression by promoting T cell infiltration

In recent years, cancer immunotherapies, represented by immune checkpoint blockade (ICB), have been highly successful and have become an important basis for the future treatment

September 12, 2023

Siegfried to acquire an early-phase CDMO in Wisconsin (US) to strengthen its Drug Substances service offering – Biotech Investments

Siegfried AG / Key word(s): Acquisition 12-Jun-2024 / 06:30 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely

June 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.